Quantification of bleomycin-induced murine lung damage in vivo with micro-computed tomography
- PMID: 17138119
- DOI: 10.1016/j.acra.2006.08.011
Quantification of bleomycin-induced murine lung damage in vivo with micro-computed tomography
Abstract
Rationale and objectives: We explored noninvasive, in vivo cone-beam microcomputed tomography (micro-CT) to visualize and quantify fibrotic and inflammatory damage over the entire lung volume of mice.
Materials and methods: We used bleomycin to induce pulmonary damage in vivo and compared the results from micro-CT with histologic measurements. Ten C57BL/6 mice were given 5 U/kg bleomycin intratracheally. Seven surviving mice were scanned with micro-CT before administration of bleomycin, and again before sacrifice. The resulting images were analyzed for lung volume measurements. After the final scan, all lungs were examined histologically and pulmonary damage was quantified. Damaged lung tissue regions were matched between micro-CT images and histologic sections for each mouse.
Results: The percent lung damage calculated from micro-CT and histology were correlated (r(2) = 0.49, r = 0.64 with P = 0.12), and the means of their respective distributions were not different (P > 0.05).
Conclusion: This study shows that micro-CT is a promising alternative to predicting lung damage caused by bleomycin. CT image volumes of the thorax allow for global tissue sampling, which may be useful when following nonuniform lung damage that can occur from intratracheal administration of bleomycin.
Similar articles
-
Semiquantitative measurement of murine bleomycin-induced lung fibrosis in in vivo and postmortem conditions using microcomputed tomography: correlation with pathologic scores--initial results.Invest Radiol. 2008 Jun;43(6):453-60. doi: 10.1097/RLI.0b013e31816900ec. Invest Radiol. 2008. PMID: 18496052
-
Imaging techniques for small animal imaging models of pulmonary disease: micro-CT.Toxicol Pathol. 2007 Jan;35(1):59-64. doi: 10.1080/01926230601184262. Toxicol Pathol. 2007. PMID: 17325973 Free PMC article.
-
Effectiveness of rosiglitazone on bleomycin-induced lung fibrosis: Assessed by micro-computed tomography and pathologic scores.Eur J Radiol. 2012 Aug;81(8):1901-6. doi: 10.1016/j.ejrad.2010.12.061. Epub 2011 Feb 5. Eur J Radiol. 2012. PMID: 21296518
-
[Bleomycin-induced pulmonary fibrosis following chemotherapy of ovarian granulosa cell tumor].Pneumologie. 1998 Jun;52(6):325-32. Pneumologie. 1998. PMID: 9715647 Review. German.
-
Sphingolipids in pulmonary fibrosis.Adv Biol Regul. 2015 Jan;57:55-63. doi: 10.1016/j.jbior.2014.09.008. Epub 2014 Oct 13. Adv Biol Regul. 2015. PMID: 25446881 Free PMC article. Review.
Cited by
-
Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P.J Immunol. 2007 Sep 15;179(6):4035-44. doi: 10.4049/jimmunol.179.6.4035. J Immunol. 2007. PMID: 17785842 Free PMC article.
-
Quantification of lung fibrosis and emphysema in mice using automated micro-computed tomography.PLoS One. 2012;7(8):e43123. doi: 10.1371/journal.pone.0043123. Epub 2012 Aug 13. PLoS One. 2012. PMID: 22912805 Free PMC article.
-
Longitudinal assessment of lung cancer progression in the mouse using in vivo micro-CT imaging.Med Phys. 2010 Sep;37(9):4793-805. doi: 10.1118/1.3476454. Med Phys. 2010. PMID: 20964199 Free PMC article.
-
Comparison between conventional and "clinical" assessment of experimental lung fibrosis.J Transl Med. 2008 Apr 10;6:16. doi: 10.1186/1479-5876-6-16. J Transl Med. 2008. PMID: 18402687 Free PMC article.
-
Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis.JCI Insight. 2016 Apr 21;1(5):e86375. doi: 10.1172/jci.insight.86375. JCI Insight. 2016. PMID: 27275013 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical